Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO(®) and OTEMTO(®) Studies

INTRODUCTION: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report recommends long-acting muscarinic antagonists (LAMA) or long-acting β(2)-agonists (LABA) as first-line treatment for chronic obstructive pulmonary disease (COPD), but many patients remain symptomatic on m...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Adv Ther
Auteurs principaux: Buhl, Roland, Singh, Dave, de la Hoz, Alberto, Xue, Wenqiong, Ferguson, Gary T.
Format: Artigo
Langue:Inglês
Publié: Springer Healthcare 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7370969/
https://ncbi.nlm.nih.gov/pubmed/32462607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01373-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires